Myocyte Enhancer Factor 2B (MEF2B) (N-Term) Peptide
-
- Target See all MEF2B products
- MEF2B (Myocyte Enhancer Factor 2B (MEF2B))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MEF2B antibody (Catalog #: ARP38696_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MEF2B (Myocyte Enhancer Factor 2B (MEF2B))
- Synonyms
- si:ch211-125m10.1 Peptide, AI451606 Peptide, RSRFR2 Peptide, myocyte enhancer factor 2b Peptide, myocyte enhancer factor 2B Peptide, mef2b Peptide, MEF2B Peptide, Mef2b Peptide
- Background
-
This gene represents numerous read-through transcripts that span geneID:729991 and 100271849. Many read-through transcripts are predicted to be nonsense-mediated decay (NMD) candidates, and are thought to be non-coding. Some transcripts are predicted to be capable of translation reinitation at a downstream AUG, resulting in expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus.
Alias Symbols: FLJ32599, FLJ46391, RSRFR2, MEF2B, LOC729991-MEF2B
Protein Size: 365 - Molecular Weight
- 39 kDa
- Gene ID
- 4207
- NCBI Accession
- NM_005919, NP_005910
- UniProt
- Q02080
-